• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Watch and Wait is Changing: We Need to Change How We Count Costs.

作者信息

Rao Christopher, Sun Myint Arthur

机构信息

Department of Colorectal Surgery, North Cumbria Integrated Care NHS Foundation Trust, Carlisle, UK.

Department of Surgery and Cancer, Imperial College London, London, UK.

出版信息

Ann Surg Oncol. 2024 Nov;31(12):7673-7675. doi: 10.1245/s10434-024-16175-y. Epub 2024 Sep 2.

DOI:10.1245/s10434-024-16175-y
PMID:39222299
Abstract
摘要

相似文献

1
Watch and Wait is Changing: We Need to Change How We Count Costs.观察等待正在改变：我们需要改变成本计算方式。
Ann Surg Oncol. 2024 Nov;31(12):7673-7675. doi: 10.1245/s10434-024-16175-y. Epub 2024 Sep 2.
2
Watch and wait for rectal cancer: assessing the cost effectiveness in Latin America.观察等待直肠癌：评估拉丁美洲的成本效益
Rev Gastroenterol Peru. 2020 Apr-Jun;40(2):204-205.
3
Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.直肠癌患者的治疗的肿瘤学结果和医院费用：观察等待策略和标准手术治疗。
Dis Colon Rectum. 2020 May;63(5):598-605. doi: 10.1097/DCR.0000000000001594.
4
Avoiding Radical Surgery in Elderly Patients With Rectal Cancer Is Cost-Effective.老年直肠癌患者避免根治性手术具有成本效益。
Dis Colon Rectum. 2017 Jan;60(1):30-42. doi: 10.1097/DCR.0000000000000708.
5
Observation versus initial treatment for prostate cancer.前列腺癌的观察与初始治疗
Ann Intern Med. 2013 Oct 15;159(8):574. doi: 10.7326/0003-4819-159-8-201310150-00016.
6
Observation versus initial treatment for prostate cancer.前列腺癌的观察与初始治疗
Ann Intern Med. 2013 Oct 15;159(8):574. doi: 10.7326/0003-4819-159-8-201310150-00015.
7
Words of wisdom. Re: Active surveillance for prostate cancer compared with immediate treatment: an economic analysis.智慧之言。关于：前列腺癌主动监测与立即治疗的比较：一项经济学分析。
Eur Urol. 2013 Nov;64(5):855. doi: 10.1016/j.eururo.2013.08.039.
8
Comparing outcomes and cost in surgery versus watch & wait surveillance of patients with rectal cancer post neoadjuvant long course chemoradiotherapy.比较新辅助长程放化疗后直肠癌患者手术与观察等待监测的结局和成本。
ANZ J Surg. 2024 Jun;94(6):1151-1160. doi: 10.1111/ans.18916. Epub 2024 Mar 15.
9
Conservative management for low-risk prostate cancer improves quality-adjusted life expectancy at lower cost compared with initial treatment.与初始治疗相比，低风险前列腺癌的保守治疗以更低的成本提高了质量调整后的预期寿命。
Evid Based Med. 2014 Feb;19(1):40. doi: 10.1136/eb-2013-101481. Epub 2013 Aug 29.
10
A Cost-Effectiveness Analysis of Contact X-ray Brachytherapy for the Treatment of Patients with Rectal Cancer Following a Partial Response to Chemoradiotherapy.接触式 X 射线近距离治疗直肠癌患者的成本效益分析：对放化疗部分缓解者。
Clin Oncol (R Coll Radiol). 2018 Mar;30(3):166-177. doi: 10.1016/j.clon.2017.11.015. Epub 2017 Dec 14.

本文引用的文献

1
ASO Author Reflections: The Economic Promise of "Watch and Wait" in Rectal Cancer: Insights from a Systematic Review.ASO作者反思：直肠癌“观察等待”策略的经济前景：一项系统评价的见解
Ann Surg Oncol. 2025 Jan;32(1):180-181. doi: 10.1245/s10434-024-16154-3. Epub 2024 Sep 3.
2
Comparing outcomes and cost in surgery versus watch & wait surveillance of patients with rectal cancer post neoadjuvant long course chemoradiotherapy.比较新辅助长程放化疗后直肠癌患者手术与观察等待监测的结局和成本。
ANZ J Surg. 2024 Jun;94(6):1151-1160. doi: 10.1111/ans.18916. Epub 2024 Mar 15.
3
Low energy contact X-ray brachytherapy for treatment of rectal cancer: a health technology appraisal by Health Technology Wales.
低能量接触式 X 射线近距离放射治疗直肠癌：威尔士卫生技术评估机构的一项卫生技术评估。
Colorectal Dis. 2024 May;26(5):1053-1058. doi: 10.1111/codi.16935. Epub 2024 Mar 11.
4
Health-Related Quality of Life in Patients With Metastatic Colorectal Cancer Undergoing Systemic Therapy With or Without Maximal Tumor Debulking.转移性结直肠癌患者接受系统治疗（含或不含最大程度肿瘤减灭术）的健康相关生活质量。
J Natl Compr Canc Netw. 2023 Oct;21(10):1059-1066.e5. doi: 10.6004/jnccn.2023.7050.
5
Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial.新辅助放化疗联合接触性X线近距离放疗增敏或外照射放疗增敏以提高早期cT2 - cT3直肠腺癌器官保留率（OPERA）：一项3期随机对照试验
Lancet Gastroenterol Hepatol. 2023 Apr;8(4):356-367. doi: 10.1016/S2468-1253(22)00392-2. Epub 2023 Feb 16.
6
The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database.新辅助治疗后采用观察等待策略管理的临床完全缓解直肠癌患者远处转移的风险：国际观察等待数据库中局部复发的影响
Dis Colon Rectum. 2023 Jan 1;66(1):41-49. doi: 10.1097/DCR.0000000000002494. Epub 2022 Oct 21.
7
The Cost-effectiveness of Watch and Wait for Rectal Cancer.直肠癌观察等待的成本效益。
Clin Oncol (R Coll Radiol). 2023 Feb;35(2):132-137. doi: 10.1016/j.clon.2022.10.002. Epub 2022 Oct 17.
8
Cost of treating metastatic colorectal cancer: a systematic review.转移性结直肠癌的治疗成本：系统评价。
Public Health. 2022 Oct;211:97-104. doi: 10.1016/j.puhe.2022.06.022. Epub 2022 Sep 2.
9
PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.PD-1 阻断在错配修复缺陷、局部晚期直肠癌中的应用。
N Engl J Med. 2022 Jun 23;386(25):2363-2376. doi: 10.1056/NEJMoa2201445. Epub 2022 Jun 5.
10
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.直肠癌患者接受全新辅助治疗后的器官保存。
J Clin Oncol. 2022 Aug 10;40(23):2546-2556. doi: 10.1200/JCO.22.00032. Epub 2022 Apr 28.